Dr. Walsh completed her hematology/oncology fellowship at Duke University in 2011 and after graduation joined the faculty at Ohio State University where she has been an integral member of the hematology division and medical education community since that time. She established a clinical niche in the care of patients with myeloproliferative neoplasms and benign hematology with a robust clinical practice. She is a founding member and leader in the newly formed Myeloproliferative Neoplasm (MPN) Clinic in the fall of 2020, and she is an NCCN panel member for Myeloproliferative Neoplasms and Systemic Mastocytosis. She has been an active contributor to clinical research in the hematology division through serving as an institutional PI or co-investigator for clinical trials in the myeloid malignancies group which has led to multiple publications. She has distinguished herself in the medical education community through institutional educational leadership positions including Internal Medicine (IM) clerkship director for the third-year medical students and hematology leader for the second-year medical students. She is actively involved at the national level through Clerkship Directors in Internal Medicine (CDIM) which is a member of the Alliance for Academic Internal Medicine (AAIM) where she has served on committees, authored manuscripts, and presented at national meetings. She has specifically been recognized within her field of hematology/oncology and education including her selection for the American Society of Clinical Oncology’s (ASCO) Education Scholars Program which ultimately led to her recruitment to Vanderbilt through her collaboration with Jill Gilbert as her small group mentor.